Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease.

Oskar Hansson, Sara Hall, Annika Ohrfelt, Henrik Zetterberg, Kaj Blennow, Lennart Minthon, Katarina Nägga, Elisabet Londos, Shiji Varghese, Nour K Majbour, Abdulmonem Al-Hayani, Omar Ma El-Agnaf

Research output: Contribution to journalArticlepeer-review

310 Downloads (Pure)

Abstract

The objective was to study whether α-synuclein oligomers are altered in the cerebrospinal fluid (CSF) of patients with dementia, including Parkinson disease with dementia (PDD), dementia with Lewy bodies (DLB), and Alzheimer disease (AD), compared with age-matched controls.
Original languageEnglish
Article number25
JournalAlzheimer's Research & Therapy
Volume6
Issue number3
DOIs
Publication statusPublished - 2014

Subject classification (UKÄ)

  • Neurology

Fingerprint

Dive into the research topics of 'Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease.'. Together they form a unique fingerprint.

Cite this